Search for: "Heath v. Merck & Co., Inc." Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2019, 6:22 am by Philipp Widera
Legal background regarding Arrow-declarations The underlying jurisdiction was established in Arrow Generics v Merck & Co Inc [2007] FSR 39 and approved by the Court of Appeal in Fujifilm v AbbVie [2017] EWCA Civ. 1. [read post]
11 Sep 2019, 1:00 pm by Oswin Ridderbusch
The specific DP IV inhibitor sitagliptin as such, however, is not identified in Royalty Pharma’s basic patent as it was developed only after the filing date of the patent (and gave rise to a distinct patent filed by Merck & Co., Inc.). [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]